JP Morgan Chase
NVO

JP Morgan Chase’s Novo Nordisk NVO Stock Holding History

JP Morgan Chase’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.9M Sell
1,612,426
-1,196,392
-43% -$51.4M ﹤0.01% 1193
2026
Q1 		$99.1M Sell
2,808,818
-724,819
-21% -$34.3M 0.01% 989
2025
Q4 		$180M Sell
3,533,637
-1,874,744
-35% -$95.9M 0.01% 706
2025
Q3 		$300M Buy
5,408,381
+2,083,583
+63% +$122M 0.02% 566
2025
Q2 		$229M Sell
3,324,798
-2,169,545
-39% -$148M 0.02% 639
2025
Q1 		$382M Sell
5,494,343
-95,400
-2% -$7.88M 0.03% 463
2024
Q4 		$481M Buy
5,589,743
+180,515
+3% +$19.5M 0.04% 393
2024
Q3 		$644M Buy
5,409,228
+472,359
+10% +$63M 0.05% 321
2024
Q2 		$705M Sell
4,936,869
-682,706
-12% -$90.5M 0.06% 292
2024
Q1 		$722M Buy
5,619,575
+877,751
+19% +$104M 0.06% 293
2023
Q4 		$491M Buy
4,741,824
+2,678,732
+130% +$265M 0.05% 356
2023
Q3 		$188M Buy
2,063,092
+198,282
+11% +$17.5M 0.02% 574
2023
Q2 		$151M Buy
1,864,810
+30,300
+2% +$2.48M 0.02% 649
2023
Q1 		$146M Sell
1,834,510
-160,970
-8% -$11.4M 0.02% 651
2022
Q4 		$135M Sell
1,995,480
-243,440
-11% -$14.3M 0.02% 655
2022
Q3 		$112M Buy
2,238,920
+1,980
+0.1% +$106K 0.02% 680
2022
Q2 		$125M Buy
2,236,940
+666,518
+42% +$37M 0.02% 665
2022
Q1 		$87.2M Buy
1,570,422
+739,582
+89% +$38M 0.01% 901
2021
Q4 		$46.5M Buy
830,840
+101,796
+14% +$5.51M 0.01% 1249
2021
Q3 		$35M Sell
729,044
-48,948
-6% -$2.37M ﹤0.01% 1375
2021
Q2 		$32.6M Buy
777,992
+44,216
+6% +$1.71M ﹤0.01% 1457
2021
Q1 		$24.7M Buy
733,776
+21,284
+3% +$758K ﹤0.01% 1575
2020
Q4 		$24.9M Buy
712,492
+29,148
+4% +$1.01M ﹤0.01% 1454
2020
Q3 		$24M Sell
683,344
-9,150
-1% -$305K ﹤0.01% 1373
2020
Q2 		$22.7M Sell
692,494
-236,480
-25% -$7.55M ﹤0.01% 1292
2020
Q1 		$28M Sell
928,974
-83,028
-8% -$2.47M 0.01% 1066
2019
Q4 		$29.3M Sell
1,012,002
-114,756
-10% -$3.18M 0.01% 1295
2019
Q3 		$29.1M Sell
1,126,758
-560
-0% -$14.2K 0.01% 1307
2019
Q2 		$28.7M Sell
1,127,318
-22,852
-2% -$565K 0.01% 1306
2019
Q1 		$30.1M Sell
1,150,170
-460,836
-29% -$11.3M 0.01% 1252
2018
Q4 		$37.1M Buy
1,611,006
+210,216
+15% +$4.67M 0.01% 1047
2018
Q3 		$33M Sell
1,400,790
-517,880
-27% -$12.6M 0.01% 1281
2018
Q2 		$44.2M Buy
1,918,670
+613,432
+47% +$14.6M 0.01% 1038
2018
Q1 		$32.1M Buy
1,305,238
+16,154
+1% +$424K 0.01% 1202
2017
Q4 		$34.6M Sell
1,289,084
-69,562
-5% -$1.77M 0.01% 1176
2017
Q3 		$32.7M Buy
1,358,646
+174,350
+15% +$3.94M 0.01% 1181
2017
Q2 		$25.4M Sell
1,184,296
-495,266
-29% -$9.99M 0.01% 1300
2017
Q1 		$28.8M Sell
1,679,562
-1,311,068
-44% -$22.8M 0.01% 1231
2016
Q4 		$53.6M Buy
2,990,630
+676,878
+29% +$12.3M 0.01% 857
2016
Q3 		$48.1M Buy
2,313,752
+1,281,080
+124% +$31.8M 0.01% 856
2016
Q2 		$27.8M Buy
1,032,672
+157,408
+18% +$4.32M 0.01% 1163
2016
Q1 		$23.7M Sell
875,264
-262,486
-23% -$7.03M 0.01% 1230
2015
Q4 		$33M Buy
1,137,750
+117,498
+12% +$3.25M 0.01% 1022
2015
Q3 		$27.7M Buy
1,020,252
+183,128
+22% +$5.18M 0.01% 1062
2015
Q2 		$22.9M Buy
837,124
+204,556
+32% +$5.75M 0.01% 1324
2015
Q1 		$16.9M Buy
632,568
+194,406
+44% +$4.48M ﹤0.01% 1549
2014
Q4 		$9.27M Sell
438,162
-27,000
-6% -$603K ﹤0.01% 2002
2014
Q3 		$11.1M Buy
465,162
+2,378
+0.5% +$54.7K ﹤0.01% 1843
2014
Q2 		$10.7M Buy
462,784
+68,096
+17% +$1.5M ﹤0.01% 1708
2014
Q1 		$9.01M Buy
394,688
+12,688
+3% +$270K ﹤0.01% 1774
2013
Q4 		$7.06M Sell
382,000
-1,716,530
-82% -$29.9M ﹤0.01% 1957
2013
Q3 		$35.5M Sell
2,098,530
-672,510
-24% -$11.3M 0.01% 990
2013
Q2 		$42.9M Buy
+2,771,040
New +$46.1M 0.01% 815

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase's NVO Position: Q2 2026 in Review

JP Morgan Chase reduced its Novo Nordisk (NVO) stake by 43% in Q2 2026, selling an estimated $51.4M and leaving 1,612,426 shares worth $77.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

JP Morgan Chase first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $722M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • JP Morgan Chase held 1,612,426 shares of Novo Nordisk worth $77.9M as of Q2 2026.
  • JP Morgan Chase sold 1,196,392 Novo Nordisk shares in Q2 2026, an estimated $51.4M.
  • Novo Nordisk made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1193 holding.
  • JP Morgan Chase first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Novo Nordisk position peaked at $722M in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.